ArticleTranslational vision science & technology2025
MEDTEG (Minimum Entropy Dynamic Test Grids): A Novel Algorithm for Adding New Test Locations to a Perimetric Test Grid.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeted perimetry for mapping the shape of glaucomatous arcuate scotomata.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To describe a novel algorithm (MEDTEG) for dynamically adding new test locations to a perimetric grid-to provide a more personalized/comprehensive visual field (VF) assessment. Methods: MEDTEG operates by finding the most informative new test location. First, Voronoi tessellation is used to construct a list of candidate locations (i.e., points that lie in between the current test locations, even when the current grid is sparse or irregular). Next, each candidate's probability mass function is computed using natural neighbor interpolation. Finally, the most informative candidate is determined by computing the expected reduction in entropy (after trial t + 1) and then multiplying this value by the area of its Voronoi cell, to estimate the overall volume of expected information gain. Optional weighting coefficients can be applied to encourage/restrict testing to particular spatial locations (e.g., to avoid the midline, target the macula, or prioritize regions exhibiting structural damage). Results: Using a combination of mathematics, graphics, and MATLAB code, we describe the algorithm and simulate possible use cases. These include ways of providing more detailed evaluations of small scotomas ("enhanced perimetry"), more efficiently assessing patients with extensive loss ("personalized perimetry"), or maximizing VF information in patients with limited attention spans ("indeterminate duration perimetry"). Conclusions: Simulations of perimetric data indicate that MEDTEG provides a logical and flexible way of automatically adding test locations to an existing perimetric test grid, or of constructing entirely novel grids based on a handful of seed locations. Translational Relevance: MEDTEG may facilitate more informative VF assessments or allow testing in challenging populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.